Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Insulin NovoRapid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
NovoRapid FlexPen 100units/ml inj 3ml pre-filled pens
0601011A0BBADAC
|
Insulin NovoRapid | Insulin aspart | Endocrine System | 197,489 |
|
NovoRapid Penfill 100units/ml inj 3ml cartridges
0601011A0BBABAB
|
Insulin NovoRapid | Insulin aspart | Endocrine System | 124,705 |
|
NovoRapid 100units/ml solution for injection 10ml vials
0601011A0BBAAAA
|
Insulin NovoRapid | Insulin aspart | Endocrine System | 58,914 |
|
NovoRapid FlexTouch 100units/ml inj 3ml pre-filled pens
0601011A0BBAEAC
|
Insulin NovoRapid | Insulin aspart | Endocrine System | 16,173 |
|
NovoRapid PumpCart 100units/ml inj 1.6ml cartridges
0601011A0BBAFAD
|
Insulin NovoRapid | Insulin aspart | Endocrine System | 11,813 |
|
NovoRapid Novolet 100units/ml solution for injection
0601011A0BBACAC
|
Insulin NovoRapid | Insulin aspart | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.